Edition:
United Kingdom

People: Alexion Pharmaceuticals Inc (ALXN.OQ)

ALXN.OQ on NASDAQ Stock Exchange Global Select Market

107.83USD
17 Sep 2019
Change (% chg)

$-0.71 (-0.65%)
Prev Close
$108.54
Open
$108.86
Day's High
$109.22
Day's Low
$107.74
Volume
548,127
Avg. Vol
708,298
52-wk High
$141.81
52-wk Low
$92.57

Coughlin, Christopher 

Mr. Christopher J. Coughlin is an Independent Director of Alexion Pharmaceuticals, Inc, He served as Advisor to the Chairman and CEO of Tyco International Ltd., a global provider of diversified products, services and industries, from 2010 to 2012, and as Executive Vice President and Chief Financial Officer of Tyco from 2005 to 2010, during a period of significant international growth and restructuring. Mr. Coughlin previously served at the Interpublic Group of Companies, Inc. as Executive Vice President, Chief Operating Officer from 2003 to 2004. From 1998 to 2003, he served as Executive Vice President and Chief Financial Officer of Pharmacia Corporation. From 1997 to1998, he was President, International at Nabisco Group Holdings and from 1996 to 1997 was Executive Vice President and Chief Financial Officer of Nabisco. From 1981 to 1996, Mr. Coughlin held various positions with Sterling Winthrop Incorporated, including Chief Financial Officer. Mr. Coughlin received a BS in accounting from Boston College.

Basic Compensation

Total Annual Compensation, USD 280,000
Restricted Stock Award, USD 253,858
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 533,858

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Brennan

448,858

Ludwig Hantson

16,490,200

Paul Clancy

5,486,510

Indrani Franchini

--

Ellen Chiniara

--

Anne-Marie Law

5,296,490
As Of  31 Dec 2018